- Tytuł:
- Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- Autorzy:
- Źródło:
- The Lancet; September 2017, Vol. 390 Issue: 10101 p1489-1498, 10p
Periodyk